Alevtina M. Orlova

Alevtina M. Orlova

Auto-generated profile, based on publicly available information

Alevtina M. Orlova

Russian Center of Forensic Medical Expertise, Moscow, Russia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Forensic Medical Expertise
Verified
Journal Article
Closed access
RKR.A. Kalyokin
R.A. Kalyokin
NMNatalia Moskaleva
Natalia Moskaleva
AVA.A. Volkova
A.A. Volkova
AOA.M. Orlova
A.M. Orlova
PMPavel Markin
Pavel Markin
SASvetlana Appolonova
Svetlana Appolonova
Was to develop a method for the qualitative and quantitative determination of benzodiazepine receptor agonists (zaleplon and clobazam), taking into account different chemical structures, by high-performance liquid chromatography-high-resolution tandem mass spectrometry using Orbitrap technology for the purposes and tasks of forensic medical examination. A method has been developed for the identification and quantitative determination of zaleplon and clobazam by high-performance liquid chromatography-high-resolution tandem mass spectrometry using Orbitrap technology. The proposed identification method can be used in the future to form a database of domestic mass spectra for potent and narcotic substances.

16 May 2023 in Forensic Medical Expertise
Verified
Journal Article
Closed access
RKR.A. Kalekin
R.A. Kalekin
SBS.S. Barseghyan
S.S. Barseghyan
AVA.A. Volkova
A.A. Volkova
AOA.M. Orlova
A.M. Orlova
VAV.D. Akimova
V.D. Akimova
The aim of the study is to suggest the method of ricin determination in biological liquids during forensic medical and chemicotoxicological examination. This research describes the optimal conditions of sample processing of biological liquids, allowing to extract the components (ricinine and ricinoleic acid) of castor seeds. The recommended analysis conditions allow to perform research for 15 minutes by high resolution mass spectrometry method combined with high-value liquid chromatography on a chromato-mass spectrometer to detect ricinine and ricinoleic acid. The chromatographic (retention time) and mass-spectrometric parameters (mass spectra) were established for the exact high-quality determination of ricinine and ricinoleic acid.

1 January 2022 in Problems of Biological, Medical and Pharmaceutical Chemistry
Verified
Journal Article
Closed access
AVA.A. Volkova
A.A. Volkova
RKR.A. Kalekin
R.A. Kalekin
AOA.M. Orlova
A.M. Orlova
PMPavel Markin
Pavel Markin
NMNatalia Moskaleva
Natalia Moskaleva
OAO.G. Astashkina
O.G. Astashkina

1 January 2022 in Forensic Medical Expertise
Verified
Journal Article
Closed access
AVA.A. Volkova
A.A. Volkova
AOA.M. Orlova
A.M. Orlova
RKR.A. Kalekin
R.A. Kalekin
SNS.R. Nevmyatova
S.R. Nevmyatova
The study objective was to determine the relevance of methods to detect clobazam poisoning during the forensic and chemical toxicological examination. The lack of a systematic approach to clobazam identification and assay as a part of forensic chemical and chemical toxicological analyses was demonstrated. The published data on the study of clobazam in biological objects are inconsistent and incomplete, precluding the conduction of focused forensic chemical and toxicological investigations on biological objects with required validity. Various methods of forensic chemical and toxicological investigation of clobazam in biological objects were studied and presented. Data are presented on various physicochemical test methods (TLC, HPLC, UV spectrometry, GC, and GC-MS) for clobazam detection.

17 December 2022 in Russian Journal of Forensic Medicine
Verified
Journal Article
Open access
PDF file
AVAlla A. Volkova
Alla A. Volkova
RKRoman A. Kalekin
Roman A. Kalekin
AOAlevtina M. Orlova
Alevtina M. Orlova
BACKGROUND: Determining the incidence of acute and lethal poisoning with clobazam remains an urgent task of analytical toxicology. The medicinal substance clobazam belongs to the group of benzodiazepines, which is included in the list of psychoactive substances whose turnover is limited because of its high toxicity profile in overdose and abuse. AIM: To propose a simple, reliable, and sensitive technique for the identification of clobazam and its metabolite in the urine by the modern high-performance liquid chromatography-tandem mass spectrometry (HPLC-QqQ-MS/MS). MATERIALS AND METHODS: We have described a simple and sensitive HPLC-QqQ-MS/MS method for the qualitative determination of clobazam in the urine. RESULTS: The retention time in the selected chromatography conditions for clobazam was 5.17 min, and its metabolite (norclobazam) in urine was 4.56 min. The base peaks for clobazam and norclobazam were 259 m/z and 245 m/z, respectively. CONCLUSION: For the first time, this study provides a validated method of chemical-toxicological examination for poisoning with clobazam by HPLC-MS/MS, tested both on a model mixture and real biological matrix of the patients urine after taking clobazam. This technique can be a confirmatory research method in addition to the clinical picture in forensic medical examination.

1 January 2022 in Forensic Medical Expertise
Verified
Journal Article
Closed access
AVA.A. Volkova
A.A. Volkova
RKR.A. Kalyokin
R.A. Kalyokin
AOA.M. Orlova
A.M. Orlova
OAO.G. Astashkina
O.G. Astashkina
The objective of the study is to evaluate the potential for the use of cards for sampling and transportation of biological material during forensic chemical and toxicological examinations by the example of a biological sample, urine containing zopiclone. Two methods of sample preparation were compared. The use of cards for the collection and transportation of biological material, such as urine, followed by high-resolution high-performance liquid chromatography-mass spectrometry (HPLC-MS) for the identification of zopiclone metabolites was shown to be beneficial in forensic chemical and toxicological examination. The validation evaluation of the proposed sample preparation and identification method met the acceptance criteria.